Home - JDNPPA

Catching Up With Past and Present Beiersdorf Residents of Distinction

A Future Dermatologist’s Journey With HS

December 2, 2024

One-on-One: TDD/JDNPPA Goes Trend Spotting With Gerry Muhle, Galderma’s Head of Global Product Strategy

November 27, 2024

Expert Perspective: What Does the Approval of Bimekizumab-bkzx (Bimzelx, UCB) Mean for The HS Community?

November 22, 2024

U.S. FDA Gives Its Nod to Bimekizumab-bkzx (Bimzelx, UCB) for HS

November 20, 2024

Advertisement

Grand Rounds: Atopic Dermatitis

Raising the Bar in Atopic Dermatitis: Unpacking the practice-changing implications of the LEVEL UP study in AD

Let’s Talk About Acne

Prescribing Hope: Exploring What’s Possible with Topical JAK Inhibition in Vitiligo

Advertisement

Latest Issue

Latest Supplement

Advertisement

Digital Edition Archive